Get the Stockscreener App
22.22
2.03%
-0.46
Pre-market:
22.22
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $22.22, with a volume of 1.23M.
It is down -2.03% in the last 24 hours and up +24.55% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
See More
Previous Close:
$22.68
Open:
$22.68
24h Volume:
1.23M
Relative Volume:
1.05
Market Cap:
$1.02B
Revenue:
$203.27M
Net Income/Loss:
$-4.66M
P/E Ratio:
-222.20
EPS:
-0.1
Net Cash Flow:
$3.47M
1W Performance:
+22.29%
1M Performance:
+24.55%
6M Performance:
+36.57%
1Y Performance:
+58.71%
1-Day Range:
$21.68
$22.99
1-Week Range:
$17.14
$23.14
52-Week Range:
$9.215
$23.14
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
22.22 | 1.05B | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
How risky is Axogen Inc. stock nowTrade Signal Summary & Daily Chart Pattern Signal Reports - newser.com
Technical analysis overview for Axogen Inc. stockEarnings Recap Report & Technical Confirmation Trade Alerts - newser.com
HC Wainwright Issues Optimistic Outlook for AxoGen Earnings - MarketBeat
AxoGen FY2025 EPS Estimate Reduced by Cantor Fitzgerald - MarketBeat
Order flow analysis tools used on Axogen Inc.2025 Winners & Losers & Growth Focused Stock Pick Reports - newser.com
Does Axogen Inc. show high probability of reboundWeekly Stock Recap & Low Drawdown Momentum Ideas - newser.com
What drives Axogen Inc stock priceMarket Capitalization Trends & Free Triple Digit Wealth Increase - earlytimes.in
Y Intercept Hong Kong Ltd Makes New Investment in AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Director Sells $826,829.25 in Stock - MarketBeat
Insider Selling: AxoGen (NASDAQ:AXGN) Director Sells 18,248 Shares of Stock - MarketBeat
Why Axogen (AXGN) Is Up 22.3% After Returning to Profitability and Raising 2025 Guidance - simplywall.st
Will Axogen Inc. stock deliver strong dividend growthJuly 2025 Pullbacks & Safe Entry Point Identification - newser.com
Axogen, Inc. Hits New 52-Week High of $22.95, Surges 217.86% - Markets Mojo
Axogen Stock Soars 23% to Intraday High Amid Strong Market Activity - Markets Mojo
Will Axogen Inc. stock gain from government policiesShort Setup & Advanced Technical Analysis Signals - newser.com
Axogen Reports Strong Q3 2025 Results, Raises Guidance - MSN
Axogen Insider Sold Shares Worth $1,246,717, According to a Recent SEC Filing - MarketScreener
Axogen Director William P. Burke Sells Over 58,000 Shares - TradingView
HC Wainwright Increases AxoGen (NASDAQ:AXGN) Price Target to $26.00 - MarketBeat
Axogen raises 2025 revenue growth target to at least 19% as BLA for Avance Nerve Graft nears key milestone - MSN
AxoGen (NASDAQ:AXGN) Stock Price Expected to Rise, Raymond James Financial Analyst Says - MarketBeat
Canaccord Genuity Group Raises AxoGen (NASDAQ:AXGN) Price Target to $27.00 - MarketBeat
3 Stocks Estimated To Be Trading Below Their Fair Value In October 2025 - simplywall.st
What’s next for Axogen Inc. stock pricePortfolio Performance Report & High Return Trade Opportunity Guides - newser.com
What the charts say about Axogen Inc. today2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Is Axogen Inc. stock attractive after correction2025 Earnings Surprises & Verified Entry Point Signals - newser.com
Is Axogen Inc. stock ready for a breakout2025 Market Overview & Expert Curated Trade Ideas - newser.com
How buybacks impact Axogen Inc. stock valueWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Axogen, Inc. (AXGN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Canaccord Genuity Maintains Axogen (AXGN) Buy Recommendation - Nasdaq
Raymond James Maintains Axogen (AXGN) Outperform Recommendation - Nasdaq
Axogen Inc (AXGN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Investing.com Canada
Axogen (AXGN): Revenue Forecast to Grow 13.8% Annually Heading Into Earnings Season - Yahoo Finance
Axogen (AXGN): HC Wainwright & Co. Raises Price Target to $26 | - GuruFocus
AxoGen stock price target raised to $28 from $22 at Leerink Partners - Investing.com Australia
Axogen Inc (AXGN) Q3 2025 Earnings Call Highlights: Strong Reven - GuruFocus
AxoGen stock price target raised to $28 from $22 at Leerink Partners By Investing.com - Investing.com South Africa
AXGN: Raymond James Raises Price Target for Axogen to $27.00 | A - GuruFocus
AxoGen (NASDAQ:AXGN) Announces Quarterly Earnings Results - MarketBeat
AxoGen (NASDAQ:AXGN) Hits New 1-Year HighShould You Buy? - MarketBeat
AxoGen (AXGN) Q3 Earnings and Revenues Top Estimates - MSN
AxoGen, Inc. (NASDAQ:AXGN) Q3 2025 Earnings Call Transcript - Insider Monkey
Multi factor analysis applied to Axogen Inc.Weekly Trade Analysis & Scalable Portfolio Growth Ideas - newser.com
Is Axogen About To Hit A Clinical Nerve With Avance Approval? - RTTNews
Citizens raises AxoGen stock price target to $34 on differentiated products By Investing.com - Investing.com South Africa
Citizens raises AxoGen stock price target to $34 on differentiated products - Investing.com
Price action breakdown for Axogen Inc.Weekly Risk Summary & Short-Term Swing Trade Alerts - newser.com
AxoGen Q3 2025 Earnings Preview - MSN
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
14.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):